CSF neurofilament levels: A potential prognostic marker in Guillain-Barré syndrome

Neurology

Volumn 67, Issue 6, 2006, Pages 1071-1073

  Petzold, A ^a,c   Hinds, N ^b   Murray, N M F ^a   Hirsch, N P ^a   Grant, D ^c   Keir, G ^c   Thompson, E J ^c   Reilly, M M ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN;

ADULT; ARTICLE; AXONAL INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MALE; NERVE FIBER DEGENERATION; NEUROFILAMENT; NEUROPHYSIOLOGY; PATHOLOGY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM;

ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GUILLAIN-BARRE SYNDROME; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEUROFILAMENT PROTEINS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 33748993683     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000237334.69665.92     Document Type: Article

References (10)

1. Wilbourn AJ, Gordon PH. Early electrodiagnostic findings in Guillain-Barre syndrome. Arch Neurol 2001;58:913-917.
2. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
3. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration & loss. J Neurol Sci 2005;233:183-198.
4. Petzold A, Keir G, Green AJE, Giovannoni G, Thompson EJ. A specific ELISA for measuring neurofilament heavy chain phosphoforms. J Immunol Methods 2003;278:179-190.
5. Merkies IS, Schmitz P, van der Meche FG, Samijn JP, van Doorn PA. Quality of life complements traditional outcome measures in immune-mediated polyneuropathies. Neurology 2002;59:84-91.
6. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Ann Neurol 1998;44:780-788.
7. Albers JW, Kelly JrJJ Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 1989;12:435-451.
8. Fletcher DD, Lawn ND, Wolter TD, Wijdicks EF. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. Neurology 2000;54:2311-2315.
9. Ng KK, Howard RS, Fish DR, et al. Management and outcome of severe Guillain-Barré syndrome. Q J Med 1995;88:243-250.
10. Plasma Exchange/Sandoglobulin Guillain-Barré Syndrome Trial Group. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome. Lancet 1997;349:225-230.